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Condensation: Risk of placenta-mediated pregnancy complications remains higher after 39 
assisted reproductive technology, and increases for hypertensive disorders in twin pregnancies 40 
and for placenta previa overall. 41 
 42 
Short title: Time trends in pregnancy complications after assisted reproductive technology. 43 
 44 
AJOG at a glance 45 
Why was this study conducted? 46 
Use of assisted reproductive technology (ART) increases worldwide with improving perinatal 47 
outcomes. We aimed to investigate changes in occurrence of placenta-mediated complications 48 
in ART pregnancies compared to the background population over three decades. 49 
 50 
Key findings 51 
 3 
ART pregnancies continue to be at higher risk, despit  declining rates of multiple 52 
pregnancies. Risk of hypertensive disorders in twinpregnancies is increasing regardless of 53 
conception method, while risk of placenta previa has increased more strongly in ART 54 
pregnancies. Risk of placental abruption risk has decreased in both populations. 55 
 56 
What does this add to what is known?  57 
Recent improvements in perinatal outcomes after ART have not been accompanied by a 58 
corresponding improvement in maternal pregnancy health in this population. Increasing risk 59 
of placenta previa requires further attention. 60 
 61 
Key words: 62 
Preeclampsia, hypertensive disorders in pregnancy, gestational hypertension, placental 63 
abruption, placenta previa, assisted reproduction, in vitro fertilization, reproductive medicine, 64 
temporal changes, twins. 65 
 66 
Abstract 67 
Background: The use of assisted reproductive technology (ART) is increasing worldwide and 68 
conception after assisted reproduction currently comprises 3-6% of birth cohorts in the Nordic 69 
countries. The risk of placenta-mediated pregnancy complications is higher after ART 70 
compared to spontaneously conceived pregnancies. Whether the excess risk of placenta-71 
mediated pregnancy complications in pregnancies following assisted reproduction has 72 
changed over time, is unknown. 73 
 74 
Objectives: To investigate whether time trends in risk of pregnancy complications 75 
(hypertensive disorders in pregnancy, placental abruption and placenta previa) differ for 76 
 4 
pregnancies after ART compared to spontaneously conceived pregnancies during three 77 
decades of assisted reproduction treatment in the Nordic countries. 78 
 79 
Study Design: In a population-based cohort study, with data from national health registries in 80 
Denmark (1994-2014), Finland (1990-2014), Norway (1988-2015) and Sweden (1988-2015), 81 
we included 6,830,578 pregnancies resulting in delivery. Among these, 146,998 (2.2%) were 82 
pregnancies after assisted reproduction (125,708 singleton pregnancies, 20,668 twin 83 
pregnancies and 622 of higher order plurality) and 6,683,132 (97.8%) pregnancies were 84 
conceived spontaneously (6,595,185 singleton pregnancies, 87,106 twin pregnancies and 85 
1,289 of higher order plurality). We used logistic regression with post-estimation to estimate 86 
absolute risks and risk differences for each complication. We repeated analyses for singleton 87 
and twin pregnancies, separately. In sub-samples with available information, we also adjusted 88 
for maternal body mass index, smoking during pregnancy, previous cesarean section, culture 89 
duration and cryopreservation. 90 
 91 
Results: The risk of each placental complication was consistently higher in pregnancies 92 
following ART compared to spontaneously conceived pregnancies across the study period, 93 
except for hypertensive disorders in twin pregnancies, where risks were similar. Risk of 94 
hypertensive disorders increased over time in twin pregnancies for both conception methods, 95 
but more strongly for pregnancies following ART (risk difference 1.73 percentage points per 96 
5 years, 95% confidence interval 1.35 to 2.11) than for spontaneously conceived twins (risk 97 
difference 0.75 percentage points, 95% confidence iterval 0.61 to 0.89). No clear time trends 98 
were found for hypertensive disorders in singleton pregnancies. Risk of placental abruption 99 
decreased over time in all groups (risk difference -0.16 percentage points, 95% confidence 100 
interval -0.19 to -0.12 and -0.06 percentage points, 95% confidence interval -0.06 to -0.05 for 101 
 5 
pregnancies after assisted reproduction and spontaneously conceived pregnancies, 102 
respectively, for singletons and multiple pregnancies combined). Over time, the risk of 103 
placenta previa increased in pregnancies after assisted reproduction among both singletons 104 
(risk difference 0.21 percentage points, 95% confidence interval 0.14 to 0.27) and twins (risk 105 
difference 0.30 percentage points, 95% confidence iterval 0.16 to 0.43), but remained stable 106 
in spontaneously conceived pregnancies. When adjusting for culture duration, the temporal 107 
increase in placenta previa became weaker in all groups of ART pregnancies, whereas 108 
adjustment for cryopreservation moderately attenuated trends in ART twin pregnancies. 109 
 110 
Conclusions: The risk of placenta-mediated pregnancy complications following ART remains 111 
higher compared to spontaneously conceived pregnancies, despite declining rates of multiple 112 
pregnancies. For hypertensive disorders in pregnancy d placental abruption, pregnancies 113 
after assisted reproduction follow the same time trends as the background population, whereas 114 





Assisted reproductive technology (ART) comprises conception methods where fertilization 120 
takes place outside the female body. Risk of placenta-mediated pregnancy complications, 121 
including preeclampsia, placental abruption and placenta previa, is higher in pregnancies after 122 
ART treatment compared to spontaneously conceived (SC) pregnancies1,2. Risk of adverse 123 
perinatal outcomes such as preterm birth, low birthweight and perinatal death is also higher3,4. 124 
This has been attributed partly to the high occurrence of multiple pregnancies after ART 125 
treatment. Still, singleton ART pregnancies also carry  higher risk of adverse outcomes 126 
 6 
compared to SC singletons1,2. The underlying causes of infertility, as well as the ART 127 
treatment itself, may both contribute to the higher risk5-8. It has been hypothesized that the 128 
super-physiological hormone levels seen in ART-cycles may alter early placentation and 129 
thereby contribute to adverse outcomes9. 130 
 131 
Worldwide, ART treatment has increased steadily over th  past decades, due to increasing 132 
availability and success rates in combination with sociodemographic changes with 133 
postponement of childbearing10. Simultaneously, perinatal outcomes after ART conception 134 
have improved and are approaching the levels of the background population, mainly due to 135 
reduction of multiple births, but also due to the improved health in ART singletons11. 136 
 137 
It seems likely that the increasing use and success rate  of ART would be accompanied by 138 
changes in the population of women seeking medical attention for infertility. Women treated 139 
with ART today comprise a larger proportion of the otal population and may therefore be 140 
more comparable to the background population than women treated some decades ago. 141 
Conversely, advances in ART12 over time may also have enabled more severely infertile 142 
women to become pregnant. Previous studies indicate th  risk of some placenta-mediated 143 
pregnancy complications, namely preeclampsia and placental abruption, is declining in the 144 
general population13,14. Whether this development also concerns ART pregnancies is 145 
unknown. 146 
 147 
The objective of this study was to investigate whether time trends in occurrence of placenta-148 
mediated pregnancy complications; hypertensive disor ers in pregnancy (HDP), placental 149 
abruption and placenta previa, differ for ART pregnancies compared to SC pregnancies 150 
during three decades of ART treatment in the Nordic countries. 151 
 7 
 152 
Material and Methods  153 
 154 
Study population and data sources 155 
 156 
The Committee of Nordic ART and Safety (CoNARTaS) study population comprises all 157 
deliveries in Denmark (1994–2014), Finland (1990–2014), Norway (1984–2015) and Sweden 158 
(1985–2015). Data were obtained from the nationwide Medical Birth Registries (MBRs) in 159 
each country, where detailed information on maternal, fetal and neonatal health for all 160 
deliveries is recorded. Individual level data from MBRs can be linked to other data sources 161 
through the unique national identity number assigned to all residents in the Nordic 162 
countries15. ART conception was determined through direct repoting to MBRs (Finland 163 
1990–2014, Norway 1984–2015 and Sweden 1985–2006), in separate notifications of all ART 164 
pregnancies at gestational week 6-7 (Norway 1984–2015) or through linkage with cycle-based 165 
ART registries (Denmark 1994–2014 and Sweden 2007–2015). 166 
From the MBRs we obtained information on birth year, plurality, birthweight, 167 
gestational age, offspring sex, parity, maternal age, smoking status in pregnancy and body 168 
mass index (BMI, measured pre-pregnancy or in first trimester). For SC pregnancies, 169 
gestational age was estimated based on ultrasound examination or on last menstrual period if 170 
information from ultrasound examination was unavailable. For ART pregnancies, gestational 171 
age was estimated based on ultrasound examination or  date of embryo transfer and culture 172 
duration, according to clinical practice in each country. 173 
 8 
Information on pregnancy complications was obtained directly from MBRs in Finland 174 
(2004–2014), Norway (1984–2015) and Sweden (1985–2015) and from data linkage with 175 
national patient registries (NPRs) in Denmark (1994–2014) and Finland (1989–2014). In the 176 
MBRs, complications are reported at delivery with lmited information on gestational age at 177 
diagnosis. In Norway, the MBR revised the notification form in 1998, changing the reporting 178 
of pregnancy complications from free text to checkboxes. For NPR data, diagnoses from each 179 
prenatal visit, delivery and postpartum controls were linked to each pregnancy using maternal 180 
identity and date of delivery. The Danish NPR comprised data from hospital admissions and 181 
outpatient visits in public specialist health care during the entire study period, and from 182 
private specialist health care since 2003. The Finnish NPR expanded its data collection in 183 
1998 from hospital admissions only to include also hospital outpatient visits. 184 
 185 
Because there were very few ART deliveries during the first years of registration, and among 186 
women of young or high reproductive ages, we restricted the study to 1988–2015 and 187 
deliveries with maternal age 22-44 years. Thus, a total of 6,830,578 deliveries among 188 
4,160,402 women were eligible. 189 
 We excluded 120,628 deliveries with missing information on one or more study 190 
variables and 12,944 deliveries with gestational age <22 or ≥45 weeks, birthweight <300 g or 191 
≥6000 g and birthweight for gestational age ≥+6 standard deviations16. Multiple pregnancies 192 
were excluded when at least one child met the exclusion criteria. Our main analysis sample 193 
included 146,998 deliveries after ART and 6,683,580 deliveries of SC pregnancies. Selection 194 
of the study population and sub-samples for sensitivity analyses are described in Figure 1. 195 
 196 
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Outcome variables 197 
Pregnancy complications were registered according to na ional adaptations of the 198 
International Classification of Diseases and related H alth Problems (ICD) classification as 199 
outlined in Supplemental Table 1. 200 
 201 
We considered HDP as a combined outcome including preeclampsia, eclampsia, gestational 202 
hypertension, and chronic hypertension with superimposed preeclampsia. We did not consider 203 
chronic hypertension as a hypertensive disorder in p egnancy because pre-pregnancy 204 
conditions cannot be a consequence of ART. For MBR data, any reporting of relevant ICD 205 
codes were considered as events, whereas the following diagnoses were included from NPRs: 206 
Diagnoses of HDP registered after 20 weeks gestation, any diagnosis of placental abruption, 207 
and any diagnosis of placenta previa in the third tr mester or within one month before 208 
delivery. 209 
 210 
Statistical analyses 211 
We used logistic regression to estimate time trends i  occurrence of pregnancy complications 212 
within the ART and SC populations. To facilitate interpretation, we used post-estimation 213 
commands to calculate absolute risks and risk differences (RDs) with 95% confidence 214 
intervals (CIs). We estimated trends over birth year categories (1988-1992, 1993-1997, 1998-215 
2002, 2003-2007, 2008-2012, 2013-2015) and as linear tr nds across the study period (change 216 
per 5 years, continuous variable). We also compared risk of each complication in ART versus 217 
SC pregnancies within each period as a measure of whether risks in the two populations 218 
converged over time. Analyses were performed on the all pregnancies, and for singletons and 219 
twins, separately. We adjusted for parity, maternal age and country. To investigate whether 220 
time trends differed between countries, we repeated nalyses for each country separately.  221 
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We performed several sensitivity analyses to investigate potential explanations for the 222 
observed trends: We repeated analyses for primiparous w men. In sub-samples with available 223 
information, we adjusted for maternal BMI and smoking. Within the ART population, we also 224 
adjusted for embryo cryopreservation (restricted to Denmark, Norway and Sweden) and 225 
culture duration (cleavage stage 2-3 days vs blastocy  stage 5-6 days, restricted to Denmark 226 
and Sweden). Next, we restricted diagnosis of placent  previa to pregnancies with delivery by 227 
cesarean section, which is required in cases of complete obstruction. Furthermore, to 228 
investigate the potential impact of a previous cesarean section, a known risk factor for 229 
placenta previa subjected to marked time trends, we adjusted for this in a sub-sample of 230 
deliveries among parous women whose first delivery was included in the study. Statistical 231 
analyses were performed using Stata/MP for Windows, Version 15.0 (StataCorp LLC, 232 
College Station, Texas, USA). 233 
 234 
Ethical considerations and approvals 235 
Approvals for data retrieval and linkage were obtained in each country. In Denmark and 236 
Finland, ethical approval is not required for research solely based on registry data. In Norway, 237 
ethical approval was given by the Regional Committee for Medical and Health Research 238 
Ethics (REC North, 2010/1909). In Sweden approval was obtained from the Ethical 239 




For the total period, deliveries after ART constituted 3.0% of birth cohorts in Denmark, 1.8% 244 
in Finland, 2.0% in Norway and 2.0% in Sweden (Table 1). There was a clear increase in 245 
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ART deliveries over time from 0.8% of all deliveries in 1988-1997 to 3.4% in 2008-2015, 246 
accompanied by a reduction of multiple pregnancies in ART from 26% in 1988-1997 to 8.7% 247 
in 2008-2015. The proportion of SC multiple pregnancies remained stable around 1.3%. 248 
Overall, parity was lower (68.0% versus 39.5% primiparous) and mean maternal age 249 
higher (33.8 versus 30.3 years) in ART compared to SC pregnancies, whereas BMI was 250 
similar between the two groups. ART mothers smoked less (5.7%) than spontaneously 251 
conceiving mothers (11.8%). Cesarean sections (30.9% versus 15.4%) and labor inductions 252 
(20.7% versus 13.4%) were more common in ART compared to SC pregnancies. 253 
 254 
Hypertensive disorders in pregnancy 255 
Risk of HDP in SC pregnancies was 4.4% (Table 2). For all pregnancies (i.e. singletons and 256 
multiples combined), risk of HDP was higher in ART compared to SC pregnancies 257 
throughout the study period (odds ratio [OR] 1.25, 95% CI 1.23 to 1.28, corresponding to a 258 
RD of 1.06 percentage points [pp]). In SC pregnancies, risk increased with 0.17 pp per 5 259 
years (95% CI 0.16 to 0.18). The increase was stronger i  twin compared to singleton 260 
pregnancies (RD 0.75 and 0.16 pp per 5 years, respectively). When adjusting for maternal 261 
smoking and BMI in a sub-sample, time trends were rv rsed in SC singletons and 262 
substantially attenuated in SC twins (Supplemental Table 2). For all ART pregnancies 263 
combined, there was no clear time trend. However, in separate analyses of singleton and twin 264 
pregnancies, development followed that in SC pregnancies (Figures 2A and 2B), with 265 
strongly increasing risk in twin pregnancies (RD 1.73 pp per 5 years, 95% CI 1.35 to 2.11) in 266 
all countries. Adjustment for maternal smoking and BMI had little influence on trends in ART 267 
pregnancies, but adjustment for cryopreservation moderately attenuated trends in ART twin 268 
pregnancies (Supplemental Table 2). 269 
 270 
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Placental abruption 271 
Risk of placental abruption in SC pregnancies was 0.43% (Table 3). Throughout the study 272 
period, risk of placental abruption was consistently higher in ART compared to SC 273 
pregnancies, both overall (OR 1.95 across the study period, 95% CI 1.83 to 2.07, 274 
corresponding to a RD of 0.40 pp) and when separating singleton and twin pregnancies. Risk 275 
of placental abruption decreased weakly over time in SC pregnancies (RD -0.06 pp per 5 276 
years, 95% CI -0.06 to -0.05), with similar trends for singleton and twin pregnancies. In ART 277 
pregnancies, the risk decrease was somewhat stronger than in SC pregnancies (RD -0.16 pp 278 
per 5 years, 95% CI -0.19 to -0.12) and of similar m gnitude in singletons and twins. Country 279 
specific analyses were compatible with results from pooled analyses (Figures 2C and 2D). In 280 
all groups, time trends remained broadly similar after additional adjustment for BMI and 281 
smoking (Supplemental Table 3). 282 
 283 
Placenta previa 284 
Risk of placenta previa in SC pregnancies was 0.34% (Table 4). Placenta previa was 285 
considerably more common in ART compared to SC pregnancies across the study period for 286 
all pregnancies combined (OR 3.87, 95% CI 3.70 to 4.04 corresponding to a RD of 0.95 pp), 287 
and for singleton and twin pregnancies separately. In SC pregnancies, risks did not 288 
substantially differ between singletons and twins, whereas for ART pregnancies, risk was 289 
somewhat higher for singletons than for twins. In SC pregnancies, risk increased weakly over 290 
time for singleton pregnancies (RD 0.03 pp per 5 years) but remained stable for twins (Figure 291 
2E). In contrast, risk increased strongly with time in ART pregnancies (RD 0.24 pp per 5 292 
years for all pluralities combined, 95% CI 0.18 to 0.30). Trends in ART pregnancies were 293 
similar for singletons and twins and were most pronounced in Denmark and Finland (Figure 294 
2F).  295 
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In sensitivity analyses, results remained similar when adjusting for smoking and BMI 296 
(Supplemental Table 4), when restricting analyses to primiparous women, when restricting 297 
diagnoses of placenta previa to those accompanied by cesarean section, and when adjusting 298 
for previous cesarean section. When adjusting for culture duration, the temporal increase in 299 
placenta previa became weaker in all groups of ART pregnancies. 300 
 301 
Comment 302 
Main findings 303 
In this registry-based cohort with nationwide data from four countries across almost three 304 
decades, we found a higher risk of placenta-mediate pr gnancy complications in ART 305 
pregnancies compared to the background population of SC children throughout the study 306 
period. For placenta previa, risk increased substantially over time in ART pregnancies, in 307 
contrast to a weakly increasing risk in the background population. For HDP, ART 308 
pregnancies followed the trends of the background population, with weakly increasing 309 
occurrence in singletons and strongly increasing occurrence in twins. Risk of placental 310 
abruption decreased over time in all groups. 311 
 312 
Results 313 
Recent meta-analyses of observational studies show positive associations between ART 314 
conception and gestational hypertension, preeclampsia, lacental abruption and placenta 315 
previa1,17. Our results are largely consistent with these studies, apart from lower risk of HDP 316 
in ART twin pregnancies compared to SC twin pregnancies. 317 
 318 
We are not aware of previous studies investigating time trends in pregnancy complications 319 
following ART conception. However, some studies of time trends in the general population 320 
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exist for these complications. In contrast to the weakly increasing rates of HDP in the general 321 
population that we observed from 1988 to 2015, Roberts et al.14 reported declining rates of 322 
gestational hypertension and preeclampsia in several Western populations, including 323 
Denmark, Norway and Sweden, during the shorter timespan from 1997 to 2007. Causes of 324 
the increasing incidence of HDP in twin pregnancies are unknown, but are not likely due to 325 
increasing gestational age, since mean gestational age did not increase in twin pregnancies 326 
across time in our study, in line with the previously reported stable occurrence of preterm 327 
birth for twin pregnancies11. 328 
 329 
Ananth et al.13 reported declining rates of placental abruption in singleton pregnancies in 330 
several Western populations, including the Nordic countries, from 1978 to 2008. They 331 
hypothesized that this might be due to changes in smoking. Our results are consistent with 332 
their study, but additionally show that risk of placental abruption has declined regardless of 333 
conception methods and multiplicity, suggesting that e development might be driven by 334 
reduction in risk factors common to all subgroups. However, smoking seemed not to explain 335 
this development, since adjustment for smoking had very little influence on trends, both for 336 
ART and SC pregnancies. 337 
 338 
An Australian cohort study showed that the risk of placenta previa in the general population 339 
increased from 0.69% to 0.87% in the years 2001–2 0918, while a Swiss population-based 340 
cohort study showed an increase in the yearly incidence of placenta previa from 0.3% to 0.5% 341 
between 1993 and 201419. Although our results support an overall increasing trend, the 342 
increase of placenta previa in the background population was much weaker. The increase in 343 
risk in ART pregnancies was considerably stronger, a finding not previously reported. 344 
Consistent with expectations from a Swedish study showing higher risk of placenta previa 345 
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after blastocyst transfer20 in a sub-sample of our Swedish study population, the increasing risk 346 
of placenta previa over time attenuated moderately fter adjustment for culture duration. 347 
 348 
Clinical implications 349 
When considering all ART pregnancies combined, risk of all complications declined 350 
considerably and approached that in the background population during the study period, 351 
mainly due to declining occurrence of multiple pregnancies, a major risk factor for adverse 352 
outcomes, after ART conception. Elective single embryo transfer (eSET) policies in the 353 
Nordic countries have led to substantial reductions n multiple pregnancies after ART, thereby 354 
also reducing risk of adverse outcomes in ART pregnancies. Thus, our results further 355 
emphasize the importance of eSET. 356 
 357 
The increasing risk of placenta previa in ART pregnancies is a matter of concern and could 358 
only partly be explained by the concurrent increase in blastocyst culture. Whether other 359 
treatment-related and thus potentially modifiable factors are involved, or whether changes in 360 
characteristics of the ART population contribute to this trend, is not yet known. 361 
 362 
Furthermore, informing clinicians and infertile couples that ART pregnancies are still at 363 
higher risk of placenta-mediated pregnancy complications despite increasing success rates and 364 
improving neonatal outcomes in ART11,21, is important. 365 
 366 
 367 
Research implications 368 
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Future studies should investigate underlying causes for the increasing occurrence of HDP in 369 
twin pregnancies. In addition, reasons behind the increasing incidence of placenta previa in 370 
ART pregnancies warrant further investigation. 371 
 372 
Strengths and limitations 373 
A key strength of this study is the large study sample with data on all deliveries in four 374 
Nordic countries over three decades, which enabled pr cisely estimated time trends in most 375 
analyses. Nonetheless, there were few events in the ART population in the earliest study 376 
period and that power was limited also in some sensitivity analyses. 377 
 378 
Another strength is that we could adjust for potential confounders such as parity, maternal age 379 
and country, as well as BMI, smoking and cesarean sction in subsamples. Still, we cannot 380 
exclude residual confounding by unmeasured factors such as causes for infertility or from 381 
misclassification of self-reported information such as smoking status. 382 
 383 
In the Nordic countries, ART treatment is strongly subsidized, ensuring that the couple’s 384 
financial situation is not a major determinant of ART conception. In combination with 385 
nationwide data sources with a very low proportion of missing data, this suggests that 386 
selection bias should be minimal. Furthermore, practic lly all pregnant women attend the 387 
publicly financed antenatal care program. In consequence, opportunities to detect pregnancy 388 
complications should not differ between the two conception methods, and the overall validity 389 
of such diagnoses is acceptable in all countries22-26. However, it is possible that women who 390 
conceive through ART have a lower threshold for seeking medical attention during 391 
pregnancy, and detection bias thus cannot be excluded. 392 
 17 
Occurrence of pregnancy complications was generally higher when extracted from 393 
patient registries (Denmark, Finland) than from MBRs only (Norway, Sweden). Changes in 394 
registration and coding practice over time may alsohave influenced the observed trends but 395 




Risk of placenta-mediated pregnancy complications fllowing ART conception is higher than 400 
for SC pregnancies in the Nordic countries. For HDP and placental abruption, ART 401 
pregnancies follow the same trends as the background population. Risk of HDP is increasing 402 
in both ART and SC twin pregnancies. Placenta previa risk has increased strongly over time 403 
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Figure captions: 514 
• FIGURE 1: Selection of the study population and sub-samples for sensitivity 515 
analyses. ART, assisted reproductive technology, SC, spontaneous conception, BMI, 516 
body mass index. Solid line arrows pointing to the right indicate exclusions, dashed 517 
line arrows pointing to the right indicate sub-sample selection. 518 
• FIGURE 2: Time trends in risk if placenta-mediated pregnancy complications 519 
according to conception method, plurality and country. ART, assisted reproductive 520 
technology, HDP, hypertensive disorders in pregnancy. Estimates ar adjusted for 521 
parity and maternal age.  522 
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 523 
aUsing z-scores from Marsal et. al where the authors developed growth curves 524 
based on ultrasonography from Swedish centers and made exclusive curves 525 
according to offspring sex 526 
bDeliveries among parous women whose first delivery was included in the main 527 
analysis sample and thus had information on delivery mode in all previous 528 
deliveries 529 
cData from Denmark (2011-2014), Norway (2011-2015) and Sweden (2006-2015) 530 










Supplemental Table 1. Overview of coding systems in use in the Nordic countries during the study period and 
selection of codes from each system.  
  International Classification of Diseases and related Health 
Problems (ICD) classification version  
  ICD-8  ICD-9  ICD-10  
Year in use        
Denmark  -  -  1994-2014  
Finland  -  1989-1995  1996-2014  
Norway  1988-1998  -  1999-2015  
Sweden  -  1988-1996  1997-2015  
        
Diagnostic codes        
Hypertensive disorders in pregnancy  637  642.3-7  O11, 013-16  
Placental abruption  632.1  641.2  O45  
Placenta previa  632.0  641.0, 641.1  O44  
  
  
Supplemental Table 2. Time trends in hypertensive disorders in pregnancies conceived after assisted reproductive technology (ART) 
and spontaneous conception. Estimates of time trends are risk differences in percentage points. 










 (95% CI) 
All pregnancies  ART Spontaneous conception 







-0.26 (-0.44 to -0.08) 
149,946/ 
3,424,972 
0.06 (0.04 to 0.08) 






-0.27 (-0.45 to -0.09) 0.03 (0.01 to 0.05) 






-0.29 (-0.46 to -0.11) -0.10 (-0.12 to -0.08) 








-0.31 (-0.49 to -0.13) -0.13 (-0.15 to -0.11) 
      





-0.02 (-0.15 to 0.12) 
172,609/ 
2,641,775 
0.29 (0.27 to 0.31) 
      




0.04 (-0.05 to 0.13) 
 
 
E) Culture duration Basic model
b
 + culture duration
f
 0.00 (-0.09 to 0.10)  
      




-0.03 (-0.05 to -0.03) 
 
 




 -0.05 (-0.08 to -0.03)  
      
Singletons   ART Spontaneous conception 





0.07 (-0.18 to 0.25) 
144,510/ 
3,380,732 
0.05 (0.03 to 0.07) 




 0.07 (-0.11 to 0.26) 0.03 (0.01 to 0.04) 




0.05 (-0.14 to 0.23) -0.10 (-0.12 to -0.09) 






0.03 (-0.15 to 0.22) -0.14 (-0.16 to -0.12) 
      
C) Primiparous  Basic model
e 6,578/ 
85,404 
0.23 (0.09 to 0.37) 
166,549/ 
2,607,276 
0.28 (0.26 to 0.30) 
      




0.07 (-0.02 to 0.16) 
 
 
E) Culture duration Basic model
b
 + culture duration
f
 0.05 (-0.04 to 0.14)  
      




0.02 (0.00 to 0.04) 
 
 




 0.00 (-0.03 to 0.02)  
      
Twins   ART Spontaneous conception 





1.52 (0.83 to 2.22) 
5,375/ 
43,690 
0.50 (0.24 to 0.75) 




 1.47 (0.76 to 2.17) 0.41 (0.15 to 0.67) 




 1.46 (0.76 to 2.16) 0.29 (0.03 to 0.55) 






 1.39 (0.68 to 2.10) 0.19 (-0.07 to 0.45) 
      





1.95 (1.46 to 2.43) 
5,963/ 
33,856 
1.19 (0.92 to 1.46) 
      




0.03 (-0.51 to 0.58) 
 
 
E) Culture duration Basic model
b
 + culture duration
f
 -0.14 (-0.69 to 0.41)  
      




0.30 (0.21 to 0.38) 
 
 




 0.23 (0.14 to 0.31)  
      
a
Per 5 years in sample B-D and per year in sample E-F. 
b









Adjusted for maternal age and country. 
f
Cleavage stage vs blastocyst transfer. 
g
Fresh vs frozen 




Supplemental Table 3. Time trends in placental abruption in pregnancies conceived after assisted reproductive technology (ART) and 
spontaneous conception. Estimates of time trends are risk differences in percentage points. 










 (95% CI) 
All pregnancies  ART Spontaneous conception 







-0.11 (-0.16 to -0.05) 
12,454/ 
3,424,972 
-0.02 (-0.03 to -0.02) 





c -0.10 (-0.15 to -0.04) -0.01 (-0.02 to -0.00) 





d -0.11 (-0.16 to -0.05) -0.02 (-0.03 to -0.02) 







d -0.10 (-0.15 to -0.05) -0.01 (-0.02 to -0.00) 
      





-0.14 (-0.18 to -0.10) 
11,079/ 
2,641,775 
-0.06 (-0.06 to -0.05) 
      




-0.05 (-0.08 to -0.02) 
 
 
E) Culture duration Basic model
b
 + culture duration
f
 -0.05 (-0.09 to -0.02)  
      




-0.04 (-0.04 to -0.03) 
 
 




 -0.03 (-0.04 to -0.02)  
      
Singletons   ART Spontaneous conception 





-0.07 (-0.12 to -0.02) 
12,046/ 
3,380,732 
-0.02 (-0.03 to -0.02) 




 -0.06 (-0.11 to -0.00) -0.01 (-0.02 to -0.01) 
B) BMI & smoking Basic model
b
 + BMI
d -0.07 (-0.12 to -0.02) -0.02 (-0.03 to -0.02) 





d -0.06 (-0.11 to -0.00) -0.01 (-0.02 to -0.01) 
      
C) Primiparous  Basic model
e 592/ 
85,404 
-0.11 (-0.15 to -0.06) 
10,779/ 
2,607,276 
-0.06 (-0.06 to -0.05) 
      




-0.04 (-0.07 to -0.01) 
 
 
E) Culture duration Basic model
b
 + culture duration
f
 -0.05 (-0.08 to -0.02)  
      




-0.02 (-0.03 to -0.02) 
 
 




 -0.02 (-0.03 to -0.02)  
      
Twins   ART Spontaneous conception 





-0.07 (-0.31 to 0.17) 
405/ 
43,690 
-0.05 (-0.12 to 0.02) 




 -0.07 (-0.31 to 0.17) -0.04 (-0.11 to 0.03) 




 -0.07 (-0.31 to 0.17) -0.06 (-0.13 to 0.01) 






 -0.07 (-0.32 to 0.17) -0.05 (-0.12 to 0.02) 
      





-0.07 (-0.24 to 0.10) 
293/ 
33,856 
-0.03 (-0.10 to 0.04) 
      




-0.15 (-0.35 to 0.05) 
 
 
E) Culture duration Basic model
b
 + culture duration
f
 -0.13 (-0.33 to 0.01)  
      




-0.03 (-0.07 to -0.00) 
 
 




 -0.03 (-0.06 to -0.00)  
      
a
Per 5 years in sample B-D and per year in sample E-F. 
b









Adjusted for maternal age and country. 
f
Cleavage stage vs blastocyst transfer. 
g
Fresh vs frozen 
embryo transfer. 
ART: Assisted reproductive technology, RD: Risk difference, CI: Confidence interval, BMI: Body mass index. 
Supplemental Table 4. Time trends in placenta previa in pregnancies conceived after assisted reproductive technology (ART) and 
spontaneous conception. Estimates of time trends are risk differences in percentage points. 










 (95% CI) 
All pregnancies  ART Spontaneous conception 







0.23 (0.13 to 0.34) 
12,492/ 
3,424,972 
0.03 (0.02 to 0.03) 






0.22 (0.11 to 0.32) 0.03 (0.02 to 0.04) 






0.24 (0.14 to 0.34) 0.03 (0.02 to 0.03) 








0.22 (0.12 to 0.32) 0.03 (0.03 to 0.04) 
      





0.25 (0.18 to 0.31) 
6,993/ 
2,641,775 
0.03 (0.02 to 0.03) 
      







0.25 (0.10 to 0.38) 
11,668/ 
3,148,760 
0.04 (0.03 to 0.05) 




+ history of 
cesarean section 
0.24 (0.10 to 0.40) 0.04 (0.03 to 0.04) 
      




0.06 (0.00 to 0.10) 
 
 
E) Culture duration Basic model
b
 + culture duration
f
 0.03 (-0.02 to 0.08)  
      




0.04 (0.03 to 0.05) 
 
 




 0.05 (0.04 to 0.06)  
      
Singletons   ART Spontaneous conception 





0.24 (0.13 to 0.35) 
12,302/ 
3,380,732 
0.03 (0.02 to 0.03) 




 0.22 (0.11 to 0.34) 0.03 (0.02 to 0.04) 
B) BMI & smoking Basic model
b
 + BMI
d 0.24 (0.13 to 0.35) 0.03 (0.02 to 0.03) 





d 0.23 (0.11 to 0.34) 0.03 (0.03 to 0.04) 
      
C) Primiparous  Basic model
e 1,402/ 
85,404 
0.22 (0.15 to 0.30) 
6,874/ 
2,607,276 
0.03 (0.02 to 0.03) 
      







0.18 (0.03 to 0.33) 
11,503/ 
3,107,064 
0.04 (0.04 to 0.05) 




+ history of 
cesarean section 
0.17 (0.02 to 0.33) 0.04 (0.03 to 0.04) 
      




0.06 (0.00 to 0.11) 
 
 
E) Culture duration Basic model
b
 + culture duration
f
 0.03 (-0.02 to 0.08)  
      




0.03 (0.02 to 0.05) 
 
 




 0.04 (0.03 to 0.06)  
      
Twins   ART Spontaneous conception 





0.08 (-0.22 to 0.37) 
189/ 
43,690 
-0.00 (-0.06 to 0.05) 




 0.05 (-0.25 to 0.35) 0.01 (-0.04 to 0.06) 




 0.08 (-0.22 to 0.37) 0.00 (-0.05 to 0.06) 






 0.05 (-0.25 to 0.35) 0.01 (-0.04 to 0.07) 
      





0.29 (0.14 to 0.44) 
118/ 
33,856 
0.03 (-0.01 to 0.08) 
      







0.34 (0.04 to 0.65) 
164/ 
41,196 
0.00 (-0.04 to 0.05) 




+ history of 
cesarean section 
0.34 (0.04 to 0.65) 0.00 (-0.05 to 0.05) 
      




0.01 (-0.17 to 0.20) 
 
 
E) Culture duration Basic model
b
 + culture duration
f
 0.00 (-0.20 to 0.20)  
      




0.05 (0.02 to 0.07) 
 
 




 0.05 (0.02 to 0.08)  
      
a
Per 5 years in sample B-D and per year in sample E-F. 
b









Adjusted for maternal age and country. 
f
Cleavage stage vs blastocyst transfer. 
g
Fresh vs frozen 
embryo transfer. 
ART: Assisted reproductive technology, RD: Risk difference, CI: Confidence interval, BMI: Body mass index. 
